Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Acasti Pharma Inc. (ACST)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsMar-31-22Mar-31-21Mar-31-20Mar-31-19Feb-29-16Feb-28-15
   10-K10-K10-K10-K20-F20-F
Revenues  0.00.20.00.00.00.0
            Revenue growth  -100.0%     
Cost of goods sold  0.20.10.00.00.00.0
Gross profit  -0.20.10.00.00.00.0
            Gross margin   61.2%    
Selling, general and administrative   [+]9.86.78.55.00.80.9
Research and development  5.64.216.029.40.40.3
Other operating expenses   0.4  -1.2-1.2
EBITDA   [+] -10.2-22.1-32.14.74.7
            EBITDA margin   -5206.6%    
Depreciation   0.10.40.42.32.3
EBITA  -15.6-10.3-22.5-32.52.32.3
            EBITA margin   -5279.6%    
Amortization of intangibles   0.81.91.92.32.3
EBIT   [+]-15.6-11.1-24.4-34.40.00.0
            EBIT margin   -5678.1%    
Non-recurring items   [+] 5.3    
Interest income  0.10.10.30.4  
Other income (expense), net  5.0-3.4-1.4-5.3  
Pre-tax income  -10.5-19.7-25.5-39.40.00.0
Income taxes  -0.60.00.00.00.00.0
            Tax rate  6.2%0.0%0.0%0.0%  
Net income  -9.8-19.7-25.5-39.40.00.0
            Net margin   -10039.8%    
   
Basic EPS   [+]($0.27)($1.33)($0.30)($0.73)  
Diluted EPS   [+]($0.27)($1.33)($0.30)($0.73)  
   
Shares outstanding (basic)   [+]36.814.884.654.3  
Shares outstanding (diluted)   [+]36.814.884.654.3  
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy